Long-term Treatment With Sequential Molecular Targeted Therapy for Xp11.2 Translocation Renal Cell Carcinoma: A Case Report and Review of the Literature-Reference-Cited by-同舟云学术

Long-term Treatment With Sequential Molecular Targeted Therapy for Xp11.2 Translocation Renal Cell Carcinoma: A Case Report and Review of the Literature

Published:2017-06 Issue:3 Volume:15 Page:e503-e506
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Kakoki Katsura,Miyata Yasuyoshi^ORCID,Mochizuki Yasushi,Iwata Takahisa,Obatake Masayuki,Abe Kuniko,Nagayasu Takeshi,Sakai Hideki

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference22 articles.

1. Population-based study of renal cell carcinoma in children in Germany, 1980-2005;Selle;Cancer,2006

2. Pediatric renal cell carcinoma;Perlman;Surg Pathol Clin,2010

3. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistory;Komai;Clin Cancer Res,2009

4. Recent advances in pediatric renal neoplasia;Argani;Adv Anat Pathol,2003

5. Molecular heterogeneity of TFE3 activation in renal cell carcinomas;Macher-Goeppinger;Mod Pathol,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive molecular characterization of TFE3-rearranged renal cell carcinoma;Experimental & Molecular Medicine;2024-08-01

2. A safe and effective treatment combination of neoadjuvant therapy and surgical resection for metastatic TFE3-rearranged renal cell carcinoma:a case report;Frontiers in Oncology;2023-10-23

3. Systemic Therapy in Patients With Metastatic Xp11.2 Translocation Renal Cell Carcinoma;Clinical Genitourinary Cancer;2022-08

4. Gene Expression Analysis of Aggressive Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical Stage T1N0M0 to Identify Potential Prognostic and Therapeutic Biomarkers;Biomedicines;2022-01-29

5. mTOR Inhibition Increases Transcription Factor E3 (TFE3) Activity and Modulates Programmed Death-Ligand 1 (PD-L1) Expression in Translocation Renal Cell Carcinoma;The American Journal of Pathology;2021-11